Skip to Main Content

Author Details

Frank J P Hoebers
Maastricht University Medical Centre
1999
124
34
PMIDPaper TitleJournal TitlePublished Year
36566991The relation between prediction model performance measures and patient selection outcomes for proton therapy in head and neck cancer.Radiother Oncol2023
37711738Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics.Front Med (Lausanne)2023
37745365A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma.medRxiv2023
37543058The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer.Radiother Oncol2023
36945519Fully-automated sarcopenia assessment in head and neck cancer: development and external validation of a deep learning pipeline.medRxiv2023
36978244Changes in survival in de novo metastatic cancer in an era of new medicines.J Natl Cancer Inst2023
37260438Multi-centre radiomics for prediction of recurrence following radical radiotherapy for head and neck cancers: Consequences of feature selection, machine learning classifiers and batch-effect harmonization.Phys Imaging Radiat Oncol2023
36880063Machine learning for normal tissue complication probability prediction: Predictive power with versatility and easy implementation.Clin Transl Radiat Oncol2023
36583567Oropharyngeal dysphagia and cachexia: Intertwined in head and neck cancer.Head Neck2023
34216399Defining High-Quality Integrated Head and Neck Cancer Care Through a Composite Outcome Measure: Textbook Outcome.Laryngoscope2022
35766141Augmenting inter-rater concordance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma: A multicenter study.Head Neck2022
35579041Additional parameters to improve the prognostic value of the 8th edition of the UICC classification for human papillomavirus-related oropharyngeal tumors.Head Neck2022
35451620Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis.Virchows Arch2022
36442320Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.EBioMedicine2022
35973619Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.Radiother Oncol2022
36193239Clinical implementation and validation of an automated adaptive workflow for proton therapy.Phys Imaging Radiat Oncol2022
36158240Independent validation of a dysphagia dose response model for the selection of head and neck cancer patients to proton therapy.Phys Imaging Radiat Oncol2022
35101464Response to "Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence".Radiother Oncol2022
34915063Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis.Radiother Oncol2022
35278135Tooth extractions prior to chemoradiation or bioradiation are associated with weight loss during treatment for locally advanced oropharyngeal cancer.Support Care Cancer2022
35243021Development of explanatory movies for the delineation of new organs at risk in neuro-oncology.Clin Transl Radiat Oncol2022
34902370Current practice in proton therapy delivery in adult cancer patients across Europe.Radiother Oncol2022
33107152Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.Head Neck2021
33545258Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment.Radiother Oncol2021
33583629Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.Eur J Surg Oncol2021
34738049Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma.JCO Precis Oncol2021
34210048A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images.Cancers (Basel)2021
34285961National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer.Int J Part Ther2021
34285938PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors.Int J Part Ther2021
34311328The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis.Oral Oncol2021
34330489Malnutrition screening in head and neck cancer patients with oropharyngeal dysphagia.Clin Nutr ESPEN2021
33189001External validation of nodal failure prediction models including radiomics in head and neck cancer.Oral Oncol2021
31536685Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma.J Cachexia Sarcopenia Muscle2020
31839429Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.Clin Nutr2020
32023504User-controlled pipelines for feature integration and head and neck radiation therapy outcome predictions.Phys Med2020
32100130Tumor control of cervical lymph node metastases of unknown primary origin: the impact of the radiotherapy target volume.Eur Arch Otorhinolaryngol2020
33137396Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures.Radiother Oncol2020
33324671Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.Front Nutr2020
32722718Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.PLoS One2020
32417345Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma.Radiother Oncol2020
32388149Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy.Radiother Oncol2020
32442178Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.PLoS One2020
32161279Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer.Sci Rep2020
32368624[<sup>18</sup>F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials.Clin Transl Radiat Oncol2020
30663068Improving decision making in larynx cancer by developing a decision aid: A mixed methods approach.Laryngoscope2019
31885424Trends in treatment and overall survival among patients with proximal esophageal cancer.World J Gastroenterol2019
30005954Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of <sup>18</sup>F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting.Radiother Oncol2019
30730570Erratum: "Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers" [Med. Phys. 45 (7), 3449-3459 (2018)].Med Phys2019
31027242Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients.Cancers (Basel)2019
28691202Methadone versus Fentanyl in Patients with Radiation-Induced Nociceptive Pain with Head and Neck Cancer: A Randomized Controlled Noninferiority Trial.Pain Pract2018
  • 1 - 50 of 124

Recommended Authors

Jason W Chan
University of California San Francisco
Career Start Year 2017
Number of shared co-authors 3
Ali Hosni
Princess Margaret Cancer Center
Career Start Year 2015
Number of shared co-authors 15
Musaddiq J Awan
Medical College of Wisconsin
Career Start Year 2013
Number of shared co-authors 4
Stefan Hartmann
University Hospital Wurzburg
Career Start Year 2013
Number of shared co-authors 0
Krupal B Patel
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 18
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 10
Katharine A Price
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 9
Julie E Bauman
George Washington University
Career Start Year 2007
Number of shared co-authors 4
Daniel J Ma
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 7
David P Goldstein
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2005
Number of shared co-authors 27
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 6
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 6
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 7
Hyunseok Kang
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 1
Barbara Bachtiary
Center for Proton Therapy, Paul Scherrer Institute
Career Start Year 2000
Number of shared co-authors 1
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 8
Beth M Beadle
Stanford University
Career Start Year 1999
Number of shared co-authors 7
Patrick K Ha
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 1
Christopher U Jones
Sutter Medical Center Sacramento
Career Start Year 1998
Number of shared co-authors 7
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 4
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 8
Robert L Foote
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 9
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 4
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 11
Danielle Van den Weyngaert
University of Antwerp
Career Start Year 1987
Number of shared co-authors 6
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 8
David I Rosenthal
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 13
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 1
Andr?? Fortin
Laval University, CHU de Quebec
Career Start Year 1980
Number of shared co-authors 6

Collaborators

Philippe Lambin
Maastricht University
Co-authored papers 27
Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers 17
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers 15
Wouter van Elmpt
Maastricht University Medical Center+
Co-authored papers 14
Johannes H A M Kaanders
Radboud University Medical Center
Co-authored papers 14
Coen R N Rasch
Leiden University Medical Center
Co-authored papers 13
Andre Dekker
Maastricht University Medical Centre
Co-authored papers 11
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers 10
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers 10
Adrian C Begg
The Netherlands Cancer Institute
Co-authored papers 9
Tito Poli
University Hospital of Parma
Co-authored papers 8
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Co-authored papers 8
Kathrin Scheckenbach
Heinrich-Heine University
Co-authored papers 8
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 8
Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Co-authored papers 7
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 7
Cary Oberije
Maastricht University Medical Centre
Co-authored papers 6
Emmanuel Rios Velazquez
Research Institute GROW, Maastricht University
Co-authored papers 6
Erik Roelofs
Maastricht University Medical Centre+
Co-authored papers 5
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 5
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 4
Hugo J W L Aerts
Harvard Medical School
Co-authored papers 4
Karel G M Moons
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Trecht University
Co-authored papers 3
Ludwig Dubois
Maastricht University
Co-authored papers 3
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Kim M Smits
Maastricht University Medical Center+
Co-authored papers 3
Jan H M Schellens
Department of Pharmaceutical Sciences, Utrecht University
Co-authored papers 2
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers 2
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Release 1.2